NEW YORK (GenomeWeb) – Affymetrix today announced three recipients of its US tumor profiling grant program.
First launched in 2014, the program is designed to support translational cancer researchers in the discovery and validation of novel diagnostic, prognostic, and therapeutic biomarkers that may address an unmet clinical need.
Qualifying grant projects must use a multi-omics, systems-based approach that analyzes data from multiple molecular and cellular levels to identify robust cancer biomarkers for future application in the clinic. The recipients are awarded with products from Affymetrix to investigate and combine analysis of at least two different analytes — DNA, RNA, or protein — across 30 tumor samples.
The 2015 grant recipients include Tamara Lotan from Johns Hopkins School of Medicine, for a project entitled "Molecular profiling to distinguish aggressive from indolent prostate cancer;" Gayle Woloschak of Northwestern University, for "Determination of biomarkers associated with cervical cancer relapse following radiation or chemo-radiation therapy;" and Antonia Sepulveda of Columbia University, for "Integrated analysis of genomic gene expression alterations for early detection in pancreatic cancer."